Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin

T. Ahmed, J. Garrigo, I. Danta

Research output: Contribution to journalArticle

194 Citations (Scopus)

Abstract

Background. We have previously reported that inhaled heparin prevents allergic bronchoconstriction in sheep and inhibits the anti-IgE-mediated release of histamine from mast cells in vitro. Since the release of such mediators has been implicated in exercise-induced asthma, we investigated whether inhaled heparin could also attenuate the bronchoconstrictor response in this disease. Methods. On five days we studied 12 subjects with a history of exercise-induced asthma. On day 1 they underwent a standardized exercise challenge on a treadmill to document the presence of exercise-induced asthma. Minute ventilation was estimated with a calibrated respiratory inductive plethysmograph. The workload was increased until the heart rate reached 85 percent of the predicted maximal value, and was sustained for 10 minutes. The magnitude of bronchoconstriction was assessed by measuring specific airway conductance before and after the exercise. On day 2 the partial- thromboplastin time was measured in plasma obtained before and after the subjects inhaled a nebulized solution of heparin (1000 U per kilogram of body weight). On days 3 through 5 the subjects were pretreated with 4 ml of inhaled heparin (1000 U per kilogram), cromolyn sodium (20 mg), or placebo according to a single-blind, randomized, crossover design and underwent exercise challenge 45 minutes later. To exclude the possibility that heparin had any direct effect on airway smooth muscle, bronchial provocation with histamine was induced in five subjects on two further days after pretreatment with either heparin or placebo. Results. Inhaled heparin and cromolyn sodium had no effect on specific airway conductance at base line, but did attenuate the exercise-induced decreases in this variable: the mean (±SE) maximal decrease five minutes after exercise was 9±5 percent after pretreatment with heparin, as compared with 22±5 percent after pretreatment with cromolyn and 35±2 percent after pretreatment with placebo. Heparin did not change the partial-thromboplastin time and did not modify the bronchoconstrictor response to histamine. Conclusions. Inhaled heparin prevents exercise- induced asthma without influencing histamine-induced bronchoconstriction. This non-anticoagulant action of heparin is more likely to be related to a modulation of mediator release than to a direct effect on smooth muscle.

Original languageEnglish
Pages (from-to)90-95
Number of pages6
JournalNew England Journal of Medicine
Volume329
Issue number2
DOIs
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

Exercise-Induced Asthma
Bronchoconstriction
Heparin
Cromolyn Sodium
Bronchoconstrictor Agents
Histamine
Partial Thromboplastin Time
Placebos
Smooth Muscle
Histamine Release
Workload
Mast Cells
Cross-Over Studies
Ventilation
Sheep
Heart Rate

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. / Ahmed, T.; Garrigo, J.; Danta, I.

In: New England Journal of Medicine, Vol. 329, No. 2, 01.01.1993, p. 90-95.

Research output: Contribution to journalArticle

Ahmed, T. ; Garrigo, J. ; Danta, I. / Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. In: New England Journal of Medicine. 1993 ; Vol. 329, No. 2. pp. 90-95.
@article{578958bc8ef145bebff70e7509605b06,
title = "Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin",
abstract = "Background. We have previously reported that inhaled heparin prevents allergic bronchoconstriction in sheep and inhibits the anti-IgE-mediated release of histamine from mast cells in vitro. Since the release of such mediators has been implicated in exercise-induced asthma, we investigated whether inhaled heparin could also attenuate the bronchoconstrictor response in this disease. Methods. On five days we studied 12 subjects with a history of exercise-induced asthma. On day 1 they underwent a standardized exercise challenge on a treadmill to document the presence of exercise-induced asthma. Minute ventilation was estimated with a calibrated respiratory inductive plethysmograph. The workload was increased until the heart rate reached 85 percent of the predicted maximal value, and was sustained for 10 minutes. The magnitude of bronchoconstriction was assessed by measuring specific airway conductance before and after the exercise. On day 2 the partial- thromboplastin time was measured in plasma obtained before and after the subjects inhaled a nebulized solution of heparin (1000 U per kilogram of body weight). On days 3 through 5 the subjects were pretreated with 4 ml of inhaled heparin (1000 U per kilogram), cromolyn sodium (20 mg), or placebo according to a single-blind, randomized, crossover design and underwent exercise challenge 45 minutes later. To exclude the possibility that heparin had any direct effect on airway smooth muscle, bronchial provocation with histamine was induced in five subjects on two further days after pretreatment with either heparin or placebo. Results. Inhaled heparin and cromolyn sodium had no effect on specific airway conductance at base line, but did attenuate the exercise-induced decreases in this variable: the mean (±SE) maximal decrease five minutes after exercise was 9±5 percent after pretreatment with heparin, as compared with 22±5 percent after pretreatment with cromolyn and 35±2 percent after pretreatment with placebo. Heparin did not change the partial-thromboplastin time and did not modify the bronchoconstrictor response to histamine. Conclusions. Inhaled heparin prevents exercise- induced asthma without influencing histamine-induced bronchoconstriction. This non-anticoagulant action of heparin is more likely to be related to a modulation of mediator release than to a direct effect on smooth muscle.",
author = "T. Ahmed and J. Garrigo and I. Danta",
year = "1993",
month = "1",
day = "1",
doi = "10.1056/NEJM199307083290204",
language = "English",
volume = "329",
pages = "90--95",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "2",

}

TY - JOUR

T1 - Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin

AU - Ahmed, T.

AU - Garrigo, J.

AU - Danta, I.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Background. We have previously reported that inhaled heparin prevents allergic bronchoconstriction in sheep and inhibits the anti-IgE-mediated release of histamine from mast cells in vitro. Since the release of such mediators has been implicated in exercise-induced asthma, we investigated whether inhaled heparin could also attenuate the bronchoconstrictor response in this disease. Methods. On five days we studied 12 subjects with a history of exercise-induced asthma. On day 1 they underwent a standardized exercise challenge on a treadmill to document the presence of exercise-induced asthma. Minute ventilation was estimated with a calibrated respiratory inductive plethysmograph. The workload was increased until the heart rate reached 85 percent of the predicted maximal value, and was sustained for 10 minutes. The magnitude of bronchoconstriction was assessed by measuring specific airway conductance before and after the exercise. On day 2 the partial- thromboplastin time was measured in plasma obtained before and after the subjects inhaled a nebulized solution of heparin (1000 U per kilogram of body weight). On days 3 through 5 the subjects were pretreated with 4 ml of inhaled heparin (1000 U per kilogram), cromolyn sodium (20 mg), or placebo according to a single-blind, randomized, crossover design and underwent exercise challenge 45 minutes later. To exclude the possibility that heparin had any direct effect on airway smooth muscle, bronchial provocation with histamine was induced in five subjects on two further days after pretreatment with either heparin or placebo. Results. Inhaled heparin and cromolyn sodium had no effect on specific airway conductance at base line, but did attenuate the exercise-induced decreases in this variable: the mean (±SE) maximal decrease five minutes after exercise was 9±5 percent after pretreatment with heparin, as compared with 22±5 percent after pretreatment with cromolyn and 35±2 percent after pretreatment with placebo. Heparin did not change the partial-thromboplastin time and did not modify the bronchoconstrictor response to histamine. Conclusions. Inhaled heparin prevents exercise- induced asthma without influencing histamine-induced bronchoconstriction. This non-anticoagulant action of heparin is more likely to be related to a modulation of mediator release than to a direct effect on smooth muscle.

AB - Background. We have previously reported that inhaled heparin prevents allergic bronchoconstriction in sheep and inhibits the anti-IgE-mediated release of histamine from mast cells in vitro. Since the release of such mediators has been implicated in exercise-induced asthma, we investigated whether inhaled heparin could also attenuate the bronchoconstrictor response in this disease. Methods. On five days we studied 12 subjects with a history of exercise-induced asthma. On day 1 they underwent a standardized exercise challenge on a treadmill to document the presence of exercise-induced asthma. Minute ventilation was estimated with a calibrated respiratory inductive plethysmograph. The workload was increased until the heart rate reached 85 percent of the predicted maximal value, and was sustained for 10 minutes. The magnitude of bronchoconstriction was assessed by measuring specific airway conductance before and after the exercise. On day 2 the partial- thromboplastin time was measured in plasma obtained before and after the subjects inhaled a nebulized solution of heparin (1000 U per kilogram of body weight). On days 3 through 5 the subjects were pretreated with 4 ml of inhaled heparin (1000 U per kilogram), cromolyn sodium (20 mg), or placebo according to a single-blind, randomized, crossover design and underwent exercise challenge 45 minutes later. To exclude the possibility that heparin had any direct effect on airway smooth muscle, bronchial provocation with histamine was induced in five subjects on two further days after pretreatment with either heparin or placebo. Results. Inhaled heparin and cromolyn sodium had no effect on specific airway conductance at base line, but did attenuate the exercise-induced decreases in this variable: the mean (±SE) maximal decrease five minutes after exercise was 9±5 percent after pretreatment with heparin, as compared with 22±5 percent after pretreatment with cromolyn and 35±2 percent after pretreatment with placebo. Heparin did not change the partial-thromboplastin time and did not modify the bronchoconstrictor response to histamine. Conclusions. Inhaled heparin prevents exercise- induced asthma without influencing histamine-induced bronchoconstriction. This non-anticoagulant action of heparin is more likely to be related to a modulation of mediator release than to a direct effect on smooth muscle.

UR - http://www.scopus.com/inward/record.url?scp=0027159470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027159470&partnerID=8YFLogxK

U2 - 10.1056/NEJM199307083290204

DO - 10.1056/NEJM199307083290204

M3 - Article

C2 - 8510708

AN - SCOPUS:0027159470

VL - 329

SP - 90

EP - 95

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 2

ER -